Apolipoprotein E ε4 allele and whole brain atrophy in late-onset Alzheimer's disease

American Journal of Psychiatry

Volumn 155, Issue 6, 1998, Pages 779-784

  Yasuda, Minoru ^a   Mori, Etsuro ^b   Kitagaki, Hajime ^b   Yamashita, Hikari ^b   Hirono, Nobutsugu ^b   Shimada, Kenichi ^b   Maeda, Kiyoshi ^b   Tanaka, Chikako ^b  

^a Hyogo Inst Aging Brain Cogn D   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; DISEASE ASSOCIATION; FEMALE; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; ANALYSIS OF VARIANCE; ANATOMY; ATROPHY; BRAIN; EDUCATIONAL STATUS; GENETICS; HISTOLOGY; HOSPITALIZATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SEX DIFFERENCE;

AGED; ALLELES; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANATOMY, CROSS-SECTIONAL; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ATROPHY; BRAIN; EDUCATIONAL STATUS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 0031596169     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Neary D, Snowden JS, Mann DMA, Bowen DM, Sims NR, Northen B, Yates PO, Davison AN: Alzheimer's disease: a correlative study. J Neurol Neurosurg Psychiatry 1986; 49:229-237
2. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R: Physical basis of cognitive alterations in Alzheimer's disease; synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30:572-580
3. Bierer LM, Hof PR, Purohit DP, Carlin L, Schmeidler J, Davis KL, Perl DP: Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol 1995; 52: 81-88
4. Mann DM: The topographic distribution of brain atrophy in Alzheimer's disease. Acta Neuropathol 1991; 83:81-86
5. Mahley RW: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240:622-630
6. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K: Apolipoprotein E immiinoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991; 541:163-166
7. Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Cram B, Goldgaber D, Roses AD: Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43:1467-1472
8. Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT: Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol 1996; 39:62-70
9. Frisoni GB, Govoni S, Geroldi C, Bianchetti A, Calabresi L, Franceschini G, Trabucchi M: Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol 1995; 37:596-604
10. Ohm TG, Kirca M, Bohl J, Scharnagl H, Gross W, Marz W: Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience 1995; 66:583-587
11. Mohs RC, Rosen WG, Davis KL: The Alzheimer's Disease Assessment Scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983; 19:448-450
12. Folstein ME, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
13. Ishii K, Kitagaki H, Kono M, Mori E: Decreased medial Temporal oxygen metabolism in Alzheimer's disease shown by PET. J Nucl Med 1996; 37:1159-1165
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
15. Sano M, Devanand DP, Richards M, Miller LW, Marder K, Bell K, Dooneief G, Bylsma FW, Lafleche G, Albert M, Folstein M, Stern Y: A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease. Arch Neurol 1995; 52:961-966
16. Wenham PR, Price WH, Blandell G: Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337:1158-1159
17. Shenton ME, Kikinis R, Jolesz FA, Pollak SD, LeMay M, Wible CG, Hokama H, Martin J, Metcalf D, Coleman M, McGarley RW: Abnormalities of the left temporal lobe and thought disorder in schizophrenia: a quantitative magnetic resonance imaging study. N Engl J Med 1992; 327:604-612
18. Yamato K, Hata Y, Kamiura N, Kobashi S, Mori E: Automatic extraction of cerebral and intracranial regions from MRI images for functional cerebral diagnosis. Visual Computing 1995; 6:96-97
19. Mori E, Hirono N, Yamashita H, Imamura T, Ikejiri Y, Ikeda M, Kitagaki H, Shimomura T, Yoneda Y: Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease. Am J Psychiatry 1997; 154:18-24
20. Jack CR, Twomey CK, Zinsmeister AR, Scarborough FW, Petersen R, Cascino GD: Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology 1989; 172:549-554
21. Yasuda M, Maeda K, Shimada K, Kakigi T, Mori E, Nakai M, Nishio H, Tanaka C: Apolipoprotein E ε4 allele and gender difference in risk of Alzheimer's disease. Alzheimer Res 1995; 1:77-81
22. Payami H, Zareparsi S, Montee KR, Sexton GJ, Kaye JA, Bird TD, Yu CE, Wijsman EM, Heston LE, Litt M, Schellenberg GD: Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 1996; 58:803-811
23. Andreasen NC, Ehrhardt JC, Swayze VWII, Alliger RJ, Yuh WT, Cohen G, Ziebell S: Magnetic resonance imaging of the brain in schizophrenia: the pathophysiologic significance of structural abnormalities. Arch Gen Psychiatry 1990; 47:35-44
24. Ho K, Roessmann U, Straumfjord JV, Monroe G: Analysis of brain weight: adult brain weight in relation to sex, race and age. Arch Pathol Lab Med 1980; 104:140-145
25. Dekaban AS, Sadowsky D: Changes in brain weight during the span of human life: relation of brain weights to body heights and body weights. Ann Neurol 1978; 4:345-356
26. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D: Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E. N EngI J Med 1996; 334:752-758
27. Small GW, Mazziotta JC, Collins MT, Baxter LR, Phelps ME, Mandelkern MA, Kaplan A, La Rue A, Adamson CF, Chang L, Guze BH, Corder EH, Saunders AM, Haines JL, Pericak-Vance MA, Roses AD: Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 1995; 273:942-947
28. Bondi MW, Salmon DP, Monsch AU, Galasko D, Butters N, Klauber MR, Thal LJ, Saitoh T: Episodic memory changes are associated with the APOE-ε4 allele in nondemented older adults. Neurology 1995; 45:2203-2206
29. Reed T, Carmelli D, Swan GE, Breitner JC, Welsh KA, Jarvik GP, Deeb S, Auwerx J: Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele. Arch Neurol 1994; 51:1189-1192
30. Helkala EL, Koivisto K, Hanninen T, Vanhanen M, Kervinen K, Kuusisto J, Mykkanen L, Kesaniemi YA, Laakso M, Riekkinen P Sr: The association of apolipoprotein E polymorphism with memory: a population-based study. Neurosci Lett 1995; 191:141-144
31. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinisto L, Halonen P, Kontula K: Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med 1995; 333:1242-1247
32. Lehtovirta M, Soininen H, Laakso MP, Partanen K, Helisaimi S, Mannermaa A, Ryynanen M, Kuikka J, Hartikainen P, Riekkinen PJ Sr: SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E ε4 allele. J Neurol Neurosurg Psychiatry 1996; 60:644-649
33. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD: Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993; 90:9649-9653
34. Poirier J: Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994; 17:525-530
35. Arriagada PV, Marzloff K, Hyman BT: Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 1992; 42:1681-1688
36. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A: Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocorrical plaques. Ann Neurol 1988; 23:138-144
37. Hatanpaa K, Brady DR, Stoll J, Rapoport SI, Chandrasekaran K: Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1996; 40:411-420